Bis(carboxymethyl)trithiocarbonate
CAS: 6326-83-6
Ref. 3D-FB166972
10g | Descatalogado | ||
25g | Descatalogado | ||
50g | Descatalogado | ||
100g | Descatalogado | ||
250g | Descatalogado |
Información del producto
- 2,2'-(Carbonothioyldisulfanediyl)Diacetate
- 2,2'-(Carbonothioyldisulfanediyl)Diacetic Acid
- 2,2′-[Carbonothioylbis(thio)]bis[acetic acid]
- 2-(Carboxymethylsulfanylcarbothioylsulfanyl)acetic acid
- 2-([[(Carboxymethyl)sulfanyl]methanethioyl]sulfanyl)acetic acid
- 3,5-Dithia-4-Thioxo-1,7-Heptanedioic Acid
- Acetic acid, 2,2′-[carbonothioylbis(thio)]bis-
- Carbonic acid, trithio-, bis(carboxymethyl) ester
- Carbonic acid, trithio-, diester with mercaptoacetic acid
- Di(carboxymethyl) trithiocarbonate
- Ver más sinónimos
- NSC 30797
- Thiocarbonyldithioglycolic acid
- Trithiocarbodiglycolic acid
Bis(carboxymethyl)trithiocarbonate (BCMT) is a potent inhibitor of Cox-2. BCMT has been shown to inhibit COX-2 activity in animals, and it was found to be safe for use in humans. BCMT also inhibits the activity of other enzymes involved in inflammation, such as lipoxygenase, 5-lipoxygenase, and cyclooxygenase. This molecule has been shown to have anti-cancer properties and is being used clinically to treat cancers with high levels of Cox-2 expression. BCMT inhibits the production of proinflammatory cytokines and chemokines that promote tumor growth by inhibiting the function of cell signaling pathways. The molecular structure of this compound contains a phosphate group, which may be responsible for its potent inhibitory activity on Cox-2 enzyme.